A Bioequivalence Study Testing Two Formulations of Sotagliflozin in Healthy Male and Female Subjects Under Fasted Conditions
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Sotagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Sanofi
- 16 May 2019 Status changed from recruiting to completed.
- 13 Feb 2019 Status changed from not yet recruiting to recruiting.
- 21 Dec 2018 New trial record